Catalent plans to invest an estimated $45 million to expand its facilities and purchase new equipment for its production ...

Novo Holdings' $16.5bn takeover of US CDMO Catalent has been completed, after months of debate over potential antitrust issues.

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

Novo Nordisk is buying three Catalent facilities for $11bn in a bid to resolve supply issues holding back growth of Ozempic for diabetes and obesity therapy Wegovy.

NJBIZ spotlights under-recognized health care leaders, from startup founders to behind-the-scenes pros driving innovation.

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

The global geriatric care services market, valued at $1 trillion in 2022, is projected to more than double by 2033, driven by ...

Novo Nordisk invests €2.34B to expand its Anagni facility near Rome, enhancing production of diabetes and obesity treatments ...

行业板块方面，2月以来7822曾夫人数码论坛申万一级行业中仅有食品饮料、综合行业出现融资净卖出，金额分别为1.01亿元、0.89亿元；其他行业均出现融资净买入，计算机、电子、通信行业融资净买入金额居前，分别为233.74亿元、209.88亿元、97.30亿元，融资资金大幅加仓科技相关板块。此外，机械设备、电力设备行业融资净买入金额均超90亿元。

Globally, $105.3 billion worth of pharmaceuticals and biotech M&A deals have been inked so far in 2025, according to data ...

全球CDMO在相关高增领域的“聚焦投入、占位战争”已经打响，这是制裁海啸余波无法阻挡的发展大趋势。

Bull or Bear, Seeking Alpha is there Markets change, but our community always has the latest in-depth analysis and powerful stock ratings. New! Get unlimited access to breaking stock news—for free.